Sinovac Biotech Ltd (SVA) — Defensive Interval Ratio
Sinovac Biotech Ltd (SVA) has a Defensive Interval Ratio of 1829 days as of June 2026. Defensive assets of $5.47 Billion (cash $-, short-term investments $5.20 Billion, receivables $265.90 Million) cover 1829 days of daily cash needs of $2.99 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Sinovac Biotech Ltd Defensive Interval Ratio (2000–2025)
This chart shows how Sinovac Biotech Ltd's Defensive Interval Ratio has evolved across 26 annual periods from 2000 to 2025. As of June 2026, the ratio stands at 1829 days, meaning defensive assets of $5.47 Billion can fund 1829 days of operations without new revenue. For the complete balance sheet picture, see SVA total assets.
Annual Defensive Interval Ratio for Sinovac Biotech Ltd (2000–2025)
The table below presents the year-by-year Defensive Interval Ratio for Sinovac Biotech Ltd from 2000 to 2025, covering 26 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital position of Sinovac Biotech Ltd to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1373 days | $5.80 Billion | $4.22 Million/day | $- | $5.48 Billion | ▼ -1119 days |
| 2024 | 2492 days | $9.91 Billion | $3.98 Million/day | $- | $9.61 Billion | ▼ -816 days |
| 2023 | 3308 days | $10.40 Billion | $3.14 Million/day | $- | $9.95 Billion | ▲ +752 days |
| 2022 | 2556 days | $7.64 Billion | $2.99 Million/day | $- | $7.03 Billion | ▲ +2139 days |
| 2021 | 417 days | $2.76 Billion | $6.61 Million/day | $- | $1.81 Billion | ▲ +209 days |
| 2020 | 209 days | $388.74 Million | $1.86 Million/day | $- | $135.25 Million | ▼ -478 days |
| 2019 | 687 days | $164.01 Million | $238.90K/day | $- | $50.27 Million | ▲ +82 days |
| 2018 | 604 days | $96.37 Million | $159.47K/day | $- | $18.91 Million | ▲ +330 days |
| 2017 | 274 days | $49.83 Million | $181.55K/day | $- | $0.00 | ▲ +0 days |
| 2016 | 274 days | $49.83 Million | $181.55K/day | $- | $0.00 | ▲ +30 days |
| 2015 | 245 days | $39.02 Million | $159.28K/day | $- | $0.00 | ▲ +52 days |
| 2014 | 193 days | $42.22 Million | $218.72K/day | $- | $1.50 Million | ▼ -44 days |
| 2013 | 237 days | $31.93 Million | $134.68K/day | $- | $- | ▼ -47 days |
| 2012 | 284 days | $23.44 Million | $82.62K/day | $- | $- | ▲ +119 days |
| 2011 | 165 days | $17.83 Million | $108.30K/day | $- | $- | ▼ -53 days |
| 2010 | 218 days | $27.28 Million | $125.36K/day | $- | $1.51 Million | ▼ -17 days |
| 2009 | 235 days | $32.85 Million | $139.76K/day | $- | $7.31 Million | ▼ -293 days |
| 2008 | 529 days | $24.96 Million | $47.23K/day | $- | $- | ▲ +225 days |
| 2007 | 303 days | $16.98 Million | $56.01K/day | $- | $1.00K | ▲ +3 days |
| 2006 | 300 days | $9.76 Million | $32.50K/day | $- | $24.00K | ▲ +108 days |
| 2005 | 192 days | $3.50 Million | $18.24K/day | $- | $149.00K | ▼ -79 days |
| 2004 | 271 days | $4.94 Million | $18.24K/day | $- | $391.00K | ▲ +113 days |
| 2003 | 158 days | $1.47 Million | $9.33K/day | $- | $- | ▲ +116 days |
| 2002 | 42 days | $15.62K | $374.83/day | $- | $- | ▲ +37 days |
| 2001 | 5 days | $9.80K | $2.12K/day | $- | $- | ▲ +0 days |
| 2000 | 5 days | $9.80K | $2.12K/day | $- | $- | — |